The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up.
about
Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessmentPhase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer.The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer.Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial.Elevated serum C-reactive protein as a prognostic marker in small cell lung cancerBrain metastases in lung cancer.Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung CancerPrognostic significance of serum LDH in small cell lung cancer: A systematic review with meta-analysis.Prophylactic cranial irradiation in patients with small-cell lung cancer: the experience at the Institute of Oncology LjubljanaChronic nasal exposure to nanoparticulate TiO2 causes pulmonary tumorigenesis in male mice.The prognostic factors in the elderly patients with small cell lung cancer: a retrospective analysis from a single cancer instituteSpecific organ metastases and survival in small cell lung cancerCombined small-cell lung carcinoma: An institutional experienceSmall cell lung cancer: treatment review.Small cell oesophageal carcinoma: an institutional experience and review of the literature.Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?Pretreatment Albumin/Globulin Ratio Predicts the Prognosis for Small-Cell Lung Cancer.Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapyConsolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study.Palliative care in poor-performance status small cell lung cancer patients: is there a mandatory role for chemotherapy?Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical setting.Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer.Serum Heat Shock Protein 70, as a Potential Biomarker for Small Cell Lung Cancer.Prognostic significance of serum neuron-specific enolase in small cell carcinoma of the urinary bladder.Lysosome-associated protein transmembrane-4β-35 is a novel independent prognostic factor in small cell lung cancer.Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients.RNA interference against polo-like kinase-1 in advanced non-small cell lung cancersEvaluation of factors associated with platinum-sensitivity status and survival in limited-stage small cell lung cancer patients treated with chemoradiotherapy.Prognostic significance of the lymphocyte-to-monocyte ratio in patients with small cell lung cancer.Efficacy of two different platinum- or anthracycline-containing chemotherapy regimens for the treatment of small cell lung cancer.High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer.Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response.A Four-Tiered Prognostic Score for Patients Receiving Palliative Thoracic Radiotherapy for Lung Cancer.Prognostic factors and survival of patients with small cell lung cancer in a northeastern Chinese population.Prognostic factors in lung cancer in a defined geographical area over two decades with a special emphasis on gender.CEA is an independent prognostic indicator that is associated with reduced survival and liver metastases in SCLC.Glial and neuronal damage markers in patients with anorexia nervosa.[Multivariate analysis of prognostic factors in the eldly patients with small cell lung cancer: a study of 160 patients].Prognostic factors in small cell lung cancer: a new prognostic index in Korean patients.Modeling the relationship between baseline lactate dehydrogenase and prognosis in patients with extensive-disease small cell lung cancer: a retrospective cohort study.
P2860
Q33274766-1D4CBB25-55F4-455D-9068-13BA9A093A49Q33400716-A24EE9C5-4CD7-4CB5-803D-479A1A7FA3FEQ33994372-55F3DEEE-EF04-4361-AC4A-040BD14CE4C2Q34370566-35765D09-2B27-4668-BA11-3560B98F117BQ35648199-9BE10F41-6A7D-4D5B-9084-0B30E9EA35E0Q35728733-861D56C6-A0B6-465F-86CF-CA1F4B09B029Q35754078-CDF0B0BF-6AB4-4E5B-BBD0-658BC59989F8Q35984979-B25C02CF-E00B-4B17-B9E7-13E7E345BF8FQ36177663-3599517B-0E72-46F1-BC4A-8B11004DB4B2Q36253580-7BF16BA4-138C-4774-8F63-BADA6BF2462BQ36261609-09BD7914-959A-4AFB-8E2F-C8C03B7BFE80Q36424117-0785103D-C3ED-4517-93CB-A02B55F1B825Q36439290-4EA1811D-EE35-4EE2-AA56-8D43AFBF2800Q36458604-AC16E238-25AA-409B-9501-1FA97654304BQ36610060-2A2DD00E-1DA9-49FC-8084-33018BFDC239Q36694116-2A11B429-94A8-4065-91C5-80DF19A4C636Q37205335-96C40F18-8D02-4F8F-BC6F-FF4624823A91Q37278502-6948382D-ABF5-406E-9876-2E8F7D8F664BQ37283557-2D70D2BD-14E4-4FB3-B82A-21931A48F940Q37982977-835E2662-842B-4B28-8451-8F55E0A53B9CQ38039073-237DE68E-E826-4AC3-BD50-CC509D5C730DQ38931288-7C17DA40-E867-4270-8B31-CABBB117DE83Q39321889-3BD75136-2021-4148-A4A7-DC93AE3FC4C9Q39765407-0EB8DBC2-AEB1-4CE9-9CB4-ECD076DD71D8Q41016802-B8E6C5C0-A553-4A27-BBCD-D0982B8332E0Q41577287-50B4FA0B-94E1-4643-8121-BB207F09A527Q41942203-40E8B280-0140-476A-AE49-5FC132DC1396Q43139088-B2041B50-AF95-48A5-98C3-4BA064A5E9E9Q45226424-EE1BEB6E-A094-4DA0-ABDB-0ED7098527B3Q46514203-96488D45-1026-49C6-8132-F5F5DC4404A9Q47119500-083ACC89-C9CA-4331-9637-02FB860044A1Q47159086-BF2BB5E9-2493-440A-AA4D-F72D94A0BD09Q47214374-631BF8C8-BA64-414A-AB4F-04B55F519C28Q50050610-33F8ABA8-BE21-48DB-B909-9A74B2B76B30Q51356299-E98D683C-E04A-4CCC-95FD-D9755F51BDEBQ51554114-0A6561E2-FC78-4396-97D4-3F9FB57DF5E9Q52919888-66102A21-F446-4F84-91F6-FD38D0A52675Q53243967-3F118640-09BC-4676-9B1A-70761CB3EDCEQ53433483-0A373B70-B173-4273-9551-9696F15124A7Q55018803-7DC7CFC1-4A9B-482C-A643-5B99B5F92320
P2860
The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The value of prognostic factor ...... with minimum 5 year follow-up.
@en
The value of prognostic factor ...... with minimum 5 year follow-up.
@nl
type
label
The value of prognostic factor ...... with minimum 5 year follow-up.
@en
The value of prognostic factor ...... with minimum 5 year follow-up.
@nl
prefLabel
The value of prognostic factor ...... with minimum 5 year follow-up.
@en
The value of prognostic factor ...... with minimum 5 year follow-up.
@nl
P2093
P1433
P1476
The value of prognostic factor ...... with minimum 5 year follow-up.
@en
P2093
Norweigian Lung Cancer Study Group
Reidulv Hatlevoll
Roy M Bremnes
Stein Sundstrom
Steinar Aamdal
Ulf Aasebø
P304
P356
10.1016/S0169-5002(02)00508-1
P50
P577
2003-03-01T00:00:00Z